This page keeps track of new/upcoming treatment options for Fabry disease. What’s in development? What’s promising? What’s available soon? Find out below… Current topics include AMT-190, gene therapy, ST-920, FLT190, AVR-RD-01, lucerastat, enzyme replacement therapy, emapalumab (NI-0501), PRX-102, and more.
Last updated: 4 years ago
Subscribe
News
Research
- Prediction of Improved Therapeutics for Fabry Disease Patients Generated by Mutagenesis of the á-Galactosidase A Active Site, Dimer Interface, and Glycosylation Region Jul 29, 2020
- Oxidative stress biomarkers in Fabry disease: is there a room for them? Jul 27, 2020
- Fabry disease: where are we now? Jul 13, 2020
- Bridging the Gap Between Vessels and Nerves in Fabry Disease Jun 16, 2020
